Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer

Research article (Gynecologic Oncology, 2018) · cited 14× · AI/ML
Press Enter · cited answer in seconds

Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer

Summary

Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer is a scholarly article[1].

Key Facts

  • Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer's instance of is recorded as scholarly article[2].

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer. Retrieved May 24, 2026, from https://4ort.xyz/entity/evaluating-class-iii-antiarrhythmic-agents-as-novel-myc-targeting-drugs-in-ovarian-cancer
MLA “Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/evaluating-class-iii-antiarrhythmic-agents-as-novel-myc-targeting-drugs-in-ovarian-cancer.
BibTeX @misc{4ortxyz_evaluating-class-iii-antiarrhythmic-agents-as-novel-myc-targeting-drugs-in-ovarian-cancer_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer}}, year = {2026}, url = {https://4ort.xyz/entity/evaluating-class-iii-antiarrhythmic-agents-as-novel-myc-targeting-drugs-in-ovarian-cancer}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer — https://4ort.xyz/entity/evaluating-class-iii-antiarrhythmic-agents-as-novel-myc-targeting-drugs-in-ovarian-cancer (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/evaluating-class-iii-antiarrhythmic-agents-as-novel-myc-targeting-drugs-in-ovarian-cancer · Last refreshed: